Objective: To evaluate outcomes of inflatable-penile-prosthesis (IPP) implantation after radical-cystectomy compared to other etiologies of erectile dysfunction.
Materials And Methods: All IPPs within the past 20 years in a large regional health system were reviewed, and erectile dysfunction (ED) etiology was determined as radical-cystectomy, radical-prostatectomy, or organic/other ED. Cohorts were generated by 1:3 propensity score match using age, body mass index, and diabetes status. Baseline demographics and relevant comorbidities were evaluated. Clavien-Dindo complications, grade, and reoperation were assessed. Multivariable logarithmic regression was used to identify the predictors of 90-day complications following IPP implantation. Log-rank analysis was used to assess the time-to-reoperation after IPP implantation in patients with a history of cystectomy compared with noncystectomy etiologies.
Results: Of 2600 patients, 231 subjects were included in the study. Comparing patients undergoing IPP for cystectomy vs pooled noncystectomy indications, those who underwent radical-cystectomy had a higher overall complication rate (24% vs 9%, p = 0.02). Clavien-Dindo complication grades did not differ across groups. Reoperation was significantly more common following cystectomy (cystectomy: 21% vs noncystectomy: 7%, p = 0.01), however time to reoperation did not differ significantly by indication (cystectomy: 8 years vs noncystectomy: 10 years,p = 0.09). Among cystectomy patients, 85% of reoperations were due to mechanical failure.
Conclusion: Compared to other erectile dysfunction etiologies, patients undergoing IPP with a history of cystectomy have an increased risk of complications within 90-days of implantation and need for surgical device revision, but no greater risk for high-grade complications. Overall IPP remains a valid treatment option after cystectomy.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.urology.2023.01.047 | DOI Listing |
Urol Res Pract
January 2025
Department of Urology, Medistate Kavacık Hospital, İstanbul, Türkiye.
Objective: To analyze data from patient information forms (PIFs) submitted to the manufacturer of a new 3-piece inflatable penile prosthesis (IPP), the Rigicon Infla10® , to summarize interim outcomes of 250 implantations in a single center, which is the largest series in Türkiye.
Methods: A retrospective review of PIFs from 250 patients implanted with the IPP between January 2021 and December 2023 was performed to assess patient characteristics, surgical data, device durability, patient satisfaction, and rates of reoperation for any reason.
Results: The mean ± SD (range) follow-up was 21.
J Comp Eff Res
January 2025
Boston Scientific Corporation; 100 Boston Scientific Way, Marlborough, MA, USA.
This study assessed the economic impact of reducing one postoperative visit following inflatable penile prosthesis (IPP) implantation. Scenario analyses were used to model the effects of eliminating one 30-min IPP postoperative visit from the expected 2.5 visits accounted for by the American Medical Association resource-based relative value scale data.
View Article and Find Full Text PDFCureus
December 2024
Department of Urology, University of Miami Miller School of Medicine, Miami, USA.
Insertion of inflatable penile prosthesis (IPP) is generally regarded as a safe procedure, with low rates of complications. However, when complications do arise, they can pose significant challenges to both patients and surgeons. Patient optimization and adherence to specific intraoperative protocols are crucial in mitigating the risk of surgical complications.
View Article and Find Full Text PDFContraception
December 2024
Department of Gynecology and Obstetrics, Tufts Medical Center, Boston, MA, USA.
Objectives: To investigate provision of immediate postpartum (iPP) highly effective contraception in Massachusetts.
Study Design: We performed logistic regressions evaluating contraceptive implant, intrauterine device, and permanent contraception procedures occuring during delivery admissions between 2017 and 2021, analyzing outcomes by method reversibility and delivery type.
Results: Hispanic and privately-insured patients had higher odds of receiving any iPP method, whereas patients delivered at non-teaching hospitals had lower odds of receiving any method.
Arch Ital Urol Androl
October 2024
Urology Department, Faculty of Medicine, Fayoum University.
Objectives: To compare the efficacy of intrathecal fentanyl and dorsal penile nerve block for postoperative pain management in patients undergoing inflatable penile prosthesis (IPP).
Patients And Methods: A prospective single-center study included 80 patients amenable to IPP. Patients were divided equally into two groups.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!